Masaru Matsuda
2021
In 2021, Masaru Matsuda earned a total compensation of $2.8M as Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary at Halozyme Therapeutics, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $205,920 |
|---|---|
| Option Awards | $450,010 |
| Salary | $457,600 |
| Stock Awards | $1,050,040 |
| Other | $594,459 |
| Total | $2,758,029 |
Matsuda received $1.1M in stock awards, accounting for 38% of the total pay in 2021.
Matsuda also received $205.9K in non-equity incentive plan, $450K in option awards, $457.6K in salary and $594.5K in other compensation.
Rankings
In 2021, Masaru Matsuda's compensation ranked 4,766th out of 12,415 executives tracked by ExecPay. In other words, Matsuda earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,766 out of 12,415 | 62nd |
Division Manufacturing | 1,985 out of 5,505 | 64th |
Major group Chemicals And Allied Products | 836 out of 2,375 | 65th |
Industry group Drugs | 748 out of 2,096 | 64th |
Industry Biological Products, Except Diagnostic Substances | 188 out of 449 | 58th |
Pay ratio
| Masaru Matsuda's Pay | $2,758,029 |
|---|---|
| Median Employee's Pay | $291,734 |
| Pay Ratio | 9to 1 |
In 2021, the annual total compensation of Masaru Matsuda was $2,758,029.
The annual total compensation of the median employee at Halozyme Therapeutics was $291,734.
The ratio of Masaru Matsuda's pay to the pay of median employee was therefore 9 to one.
Source: SEC filing on March 25, 2022.
Matsuda's colleagues
We found three more compensation records of executives who worked with Masaru Matsuda at Halozyme Therapeutics in 2021.